The Changing Face of Breast Cancer – Past, Presentand Future Perspectives Michael Baum OriginalPaper Pages: 1 - 5
Tamoxifen – An Update on Current Data and Where it Can Now be Used Lawrence Wickerham OriginalPaper Pages: 7 - 12
New Generation Aromatase Inhibitors – from the Advanced to the Adjuvant Setting Aman U. Buzdar OriginalPaper Pages: 13 - 17
A New Estrogen Receptor Antagonist – An Overview of Available Data Stephen E. Jones OriginalPaper Pages: 19 - 21
Overview of Luteinizing Hormone-Releasing Hormone Agonists in Early Breast Cancer – Benefits of Reversible Ovarian Ablation Walter Jonat OriginalPaper Pages: 23 - 26
Sequencing of Endocrine Therapies in Breast Cancer – Integration of Recent Data Robert C. Carlson OriginalPaper Pages: 27 - 32
Choosing between Endocrine Therapy and Chemotherapy – or is there a Role for Combination Therapy? John F. ForbesWilliam J. GradisharPeter M. Ravdin OriginalPaper Pages: 37 - 44
The Role of EGFR-Directed Therapy in the Treatment of Breast Cancer Charles Morris OriginalPaper Pages: 51 - 55
The Status of Breast Cancer Management: Challenges and Opportunities Gabriel N. Hortobagyi OriginalPaper Pages: 61 - 65